Das28 responses in patients with active rheumatoid arthritis who received golimumab and methotrexate: A randomized, double-blind, placebo-controlled phase 2 trial

Kay, J.; Matteson, E. L.; Dasgupta, B.; Nash, P.; Durezs, P.; Hall, S.; Han, J.; Rahman, M. U.

Das28 responses in patients with active rheumatoid arthritis who received golimumab and methotrexate: A randomized, double-blind, placebo-controlled phase 2 trial

Kay, J.

;

Matteson, E. L.

;

Dasgupta, B.

;

Nash, P.

;

Rahman, M. U.

;et.al.

(2006) Annual European Congress of Rheumatology (EULAR 2006) — Location: Amsterdam(Netherlands) (21.June.2006)

Files

No attached file found for this publication.

Details

Authors

Kay, J.
Author
Matteson, E. L.
Author
Dasgupta, B.
Author
Nash, P.
Author
Rahman, M. U.
Author

Affiliations

UCLouvainAutre

Citations

APA
Chicago
FWB

Kay, J., Matteson, E. L., Dasgupta, B., Nash, P., Durezs, P., Hall, S., Han, J., & Rahman, M. U. (2006). Das28 responses in patients with active rheumatoid arthritis who received golimumab and methotrexate: A randomized, double-blind, placebo-controlled phase 2 trial. Annals of the Rheumatic Diseases, 65, 323. https://hdl.handle.net/2078.5/148498 (Original work published 2006)